{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T05:06:46Z","timestamp":1792904806744,"version":"4.5.0"},"reference-count":97,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T00:00:00Z","timestamp":1737331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T00:00:00Z","timestamp":1737331200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Probiotics & Antimicro. Prot."],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1007\/s12602-025-10455-z","type":"journal-article","created":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T02:47:53Z","timestamp":1737341273000},"page":"1217-1235","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["New Frontiers in Fighting Mycobacterial Infections: Venom-Derived Peptides"],"prefix":"10.1007","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1026-140X","authenticated-orcid":false,"given":"Hamed","family":"Memariani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4964-3117","authenticated-orcid":false,"given":"Mojtaba","family":"Memariani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,20]]},"reference":[{"issue":"17","key":"10455_CR1","doi-asserted-by":"publisher","first-page":"e01180","DOI":"10.1128\/AEM.01180-19","volume":"85","author":"CM Walsh","year":"2019","unstructured":"Walsh CM, Gebert MJ, Delgado-Baquerizo M, Maestre FT, Fierer N (2019) A global survey of mycobacterial diversity in soil. Appl Environ Microbiol 85(17):e01180-e1219. https:\/\/doi.org\/10.1128\/AEM.01180-19","journal-title":"Appl Environ Microbiol"},{"issue":"1","key":"10455_CR2","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1021\/acs.jproteome.0c00650","volume":"20","author":"C Hermann","year":"2020","unstructured":"Hermann C, Karamchand L, Blackburn JM, Soares NC (2020) Cell envelope proteomics of mycobacteria. J Proteome Res 20(1):94\u2013109. https:\/\/doi.org\/10.1021\/acs.jproteome.0c00650","journal-title":"J Proteome Res"},{"key":"10455_CR3","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.meegid.2019.01.017","volume":"72","author":"CY Turenne","year":"2019","unstructured":"Turenne CY (2019) Nontuberculous mycobacteria: insights on taxonomy and evolution. Infect Genet Evol 72:159\u2013168. https:\/\/doi.org\/10.1016\/j.meegid.2019.01.017","journal-title":"Infect Genet Evol"},{"issue":"1","key":"10455_CR4","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1080\/10408410601172271","volume":"33","author":"T Hussain","year":"2007","unstructured":"Hussain T (2007) Leprosy and tuberculosis: an insight-review. Crit Rev Microbiol 33(1):15\u201366. https:\/\/doi.org\/10.1080\/10408410601172271","journal-title":"Crit Rev Microbiol"},{"key":"10455_CR5","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1007\/s10096-019-03771-0","volume":"39","author":"KL Chin","year":"2020","unstructured":"Chin KL, Sarmiento ME, Alvarez-Cabrera N, Norazmi MN, Acosta A (2020) Pulmonary non-tuberculous mycobacterial infections: current state and future management. Eur J Clin Microbiol Infect Dis 39:799\u2013826. https:\/\/doi.org\/10.1007\/s10096-019-03771-0","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"3","key":"10455_CR6","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/S2213-2600(15)00063-6","volume":"3","author":"A Zumla","year":"2015","unstructured":"Zumla A, Chakaya J, Centis R, D\u2019Ambrosio L, Mwaba P, Bates M, Kapata N, Nyirenda T, Chanda D, Mfinanga S, Hoelscher M, Maeurer M, Migliori GB (2015) Tuberculosis treatment and management\u2014an update on treatment regimens, trials, new drugs, and adjunct therapies. Lancet Respir Med 3(3):220\u2013234. https:\/\/doi.org\/10.1016\/S2213-2600(15)00063-6","journal-title":"Lancet Respir Med"},{"key":"10455_CR7","unstructured":"World Health Organization (WHO). 2024 Tuberculosis resurges as top infectious disease killer, Accessed December 5, 2024 at: https:\/\/www.who.int\/news\/item\/29-10-2024-tuberculosis-resurges-as-top-infectious-disease-killer"},{"issue":"1","key":"10455_CR8","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1186\/s12879-024-09079-5","volume":"24","author":"H Lv","year":"2024","unstructured":"Lv H, Zhang X, Zhang X, Bai J, You S, Li X, Li S, Wang Y, Zhang W, Xu Y (2024) Global prevalence and burden of multidrug-resistant tuberculosis from 1990 to 2019. BMC Infect Dis 24(1):243. https:\/\/doi.org\/10.1186\/s12879-024-09079-5","journal-title":"BMC Infect Dis"},{"issue":"6","key":"10455_CR9","doi-asserted-by":"publisher","first-page":"5202","DOI":"10.3390\/ijms24065202","volume":"24","author":"SS Alsayed","year":"2023","unstructured":"Alsayed SS, Gunosewoyo H (2023) Tuberculosis: pathogenesis, current treatment regimens and new drug targets. Int J Mol Sci 24(6):5202. https:\/\/doi.org\/10.3390\/ijms24065202","journal-title":"Int J Mol Sci"},{"issue":"4","key":"10455_CR10","doi-asserted-by":"publisher","first-page":"ofae128","DOI":"10.1093\/ofid\/ofae128","volume":"11","author":"C Cimino","year":"2024","unstructured":"Cimino C, Rivera CG, Pearson JC, Colton B, Slain D, Mahoney MV (2024) Pharmacotherapeutic considerations in the treatment of nontuberculous mycobacterial infections: a primer for clinicians. Open Forum Infect Dis 11(4):ofae128. https:\/\/doi.org\/10.1093\/ofid\/ofae128","journal-title":"Open Forum Infect Dis"},{"key":"10455_CR11","doi-asserted-by":"publisher","first-page":"1394220","DOI":"10.3389\/fmicb.2024.1394220","volume":"15","author":"LE Conyers","year":"2024","unstructured":"Conyers LE, Saunders BM (2024) Treatment for non-tuberculous mycobacteria: challenges and prospects. Front Microbiol 15:1394220. https:\/\/doi.org\/10.3389\/fmicb.2024.1394220","journal-title":"Front Microbiol"},{"issue":"2","key":"10455_CR12","doi-asserted-by":"publisher","first-page":"96","DOI":"10.3390\/biology10020096","volume":"10","author":"S Saxena","year":"2021","unstructured":"Saxena S, Spaink HP, Forn-Cun\u00ed G (2021) Drug resistance in nontuberculous mycobacteria: mechanisms and models. Biology 10(2):96. https:\/\/doi.org\/10.3390\/biology10020096","journal-title":"Biology"},{"key":"10455_CR13","unstructured":"Centers for Disease Control and Prevention (CDC). 2021 State and City TB Report: sputum culture conversion, Accessed December 4, 2024 at: https:\/\/www.cdc.gov\/tb-data\/2021-state-city-report\/sputum-culture-conversion.html"},{"issue":"1","key":"10455_CR14","doi-asserted-by":"publisher","first-page":"18073","DOI":"10.1038\/s41598-024-68636-9","volume":"14","author":"R Arora","year":"2024","unstructured":"Arora R, Nadar K, Bajpai U (2024) Discovery and characterization of a novel LysinB from F2 sub-cluster mycobacteriophage RitSun. Sci Rep 14(1):18073. https:\/\/doi.org\/10.1038\/s41598-024-68636-9","journal-title":"Sci Rep"},{"key":"10455_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2021.113732","volume":"224","author":"G Cazzaniga","year":"2021","unstructured":"Cazzaniga G, Mori M, Chiarelli LR, Gelain A, Meneghetti F, Villa S (2021) Natural products against key Mycobacterium tuberculosis enzymatic targets: emerging opportunities for drug discovery. Eur J Med Chem 224:113732. https:\/\/doi.org\/10.1016\/j.ejmech.2021.113732","journal-title":"Eur J Med Chem"},{"issue":"11","key":"10455_CR16","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.3390\/biom10111566","volume":"10","author":"JL Medina-Franco","year":"2020","unstructured":"Medina-Franco JL, Sald\u00edvar-Gonz\u00e1lez FI (2020) Cheminformatics to characterize pharmacologically active natural products. Biomolecules 10(11):1566. https:\/\/doi.org\/10.3390\/biom10111566","journal-title":"Biomolecules"},{"issue":"3","key":"10455_CR17","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1021\/acs.jnatprod.9b01285","volume":"83","author":"DJ Newman","year":"2020","unstructured":"Newman DJ, Cragg GM (2020) Natural products as sources of new drugs over the nearly four decades from 01\/1981 to 09\/2019. J Nat Prod 83(3):770\u2013803. https:\/\/doi.org\/10.1021\/acs.jnatprod.9b01285","journal-title":"J Nat Prod"},{"key":"10455_CR18","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1126\/science.aau7761","volume":"361","author":"M Holford","year":"2018","unstructured":"Holford M, Daly M, King GF, Norton RS (2018) Venoms to the rescue. Science 361:842\u2013844. https:\/\/doi.org\/10.1126\/science.aau7761","journal-title":"Science"},{"issue":"17\u201318","key":"10455_CR19","doi-asserted-by":"publisher","first-page":"1900324","DOI":"10.1002\/pmic.201900324","volume":"20","author":"AA Walker","year":"2020","unstructured":"Walker AA, Robinson SD, Hamilton BF, Undheim EA, King GF (2020) Deadly proteomes: a practical guide to proteotranscriptomics of animal venoms. Proteomics 20(17\u201318):1900324. https:\/\/doi.org\/10.1002\/pmic.201900324","journal-title":"Proteomics"},{"issue":"4","key":"10455_CR20","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1002\/bies.201000117","volume":"33","author":"FJ Vonk","year":"2011","unstructured":"Vonk FJ, Jackson K, Doley R, Madaras F, Mirtschin PJ, Vidal N (2011) Snake venom: from fieldwork to the clinic: recent insights into snake biology, together with new technology allowing high-throughput screening of venom, bring new hope for drug discovery. BioEssays 33(4):269\u2013279. https:\/\/doi.org\/10.1002\/bies.201000117","journal-title":"BioEssays"},{"issue":"1","key":"10455_CR21","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s10096-019-03674-0","volume":"39","author":"H Memariani","year":"2020","unstructured":"Memariani H, Memariani M, Moravvej H, Shahidi-Dadras M (2020) Melittin: a venom-derived peptide with promising anti-viral properties. Eur J Clin Microbiol Infect Dis 39(1):5\u201317. https:\/\/doi.org\/10.1007\/s10096-019-03674-0","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"21","key":"10455_CR22","doi-asserted-by":"publisher","first-page":"12773","DOI":"10.1021\/acs.jmedchem.0c01107","volume":"63","author":"A Peschel","year":"2020","unstructured":"Peschel A, Cardoso FC, Walker AA, Durek T, Stone MRL, Emidio NB, Dawson PE, Muttenthaler M, King GF (2020) Two for the price of one: heterobivalent ligand design targeting two binding sites on voltage-gated sodium channels slows ligand dissociation and enhances potency. J Med Chem 63(21):12773\u201312785. https:\/\/doi.org\/10.1021\/acs.jmedchem.0c01107","journal-title":"J Med Chem"},{"issue":"10","key":"10455_CR23","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1080\/17460441.2021.1922386","volume":"16","author":"TB Smallwood","year":"2021","unstructured":"Smallwood TB, Clark RJ (2021) Advances in venom peptide drug discovery: where are we at and where are we heading? Expert Opin Drug Discov 16(10):1163\u20131173. https:\/\/doi.org\/10.1080\/17460441.2021.1922386","journal-title":"Expert Opin Drug Discov"},{"issue":"4046","key":"10455_CR24","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1126\/science.177.4046.314","volume":"177","author":"E Habermann","year":"1972","unstructured":"Habermann E (1972) Bee and wasp venoms. Science 177(4046):314\u2013322. https:\/\/doi.org\/10.1126\/science.177.4046.314","journal-title":"Science"},{"key":"10455_CR25","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s10989-024-10606-w","volume":"30","author":"M Memariani","year":"2024","unstructured":"Memariani M, Memariani H (2024) Anti-biofilm effects of melittin: lessons learned and the path ahead. Int J Pept Res Ther 30:29. https:\/\/doi.org\/10.1007\/s10989-024-10606-w","journal-title":"Int J Pept Res Ther"},{"issue":"2","key":"10455_CR26","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.bbamem.2009.07.014","volume":"1798","author":"R Saravanan","year":"2010","unstructured":"Saravanan R, Bhunia A, Bhattacharjya S (2010) Micelle-bound structures and dynamics of the hinge deleted analog of melittin and its diastereomer: implications in cell selective lysis by d-amino acid containing antimicrobial peptides. Biochim Biophys Acta 1798(2):128\u2013139. https:\/\/doi.org\/10.1016\/j.bbamem.2009.07.014","journal-title":"Biochim Biophys Acta"},{"key":"10455_CR27","doi-asserted-by":"publisher","first-page":"3265","DOI":"10.1007\/s00253-019-09698-y","volume":"103","author":"H Memariani","year":"2019","unstructured":"Memariani H, Memariani M, Shahidi-Dadras M, Nasiri S, Akhavan MM, Moravvej H (2019) Melittin: from honeybees to superbugs. Appl Microbiol Biotechnol 103:3265\u20133276. https:\/\/doi.org\/10.1007\/s00253-019-09698-y","journal-title":"Appl Microbiol Biotechnol"},{"issue":"2","key":"10455_CR28","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1099\/jmm.0.000912","volume":"68","author":"E Portell-Buj","year":"2019","unstructured":"Portell-Buj E, Vergara A, Alejo I, L\u00f3pez-Gav\u00edn A, Mont\u00e9 MR, San Nicol\u00e1s L, Gonz\u00e1lez-Mart\u00edn J, Tud\u00f3 G (2019) In vitro activity of 12 antimicrobial peptides against Mycobacterium tuberculosis and Mycobacterium avium clinical isolates. J Med Microbiol 68(2):211\u2013215. https:\/\/doi.org\/10.1099\/jmm.0.000912","journal-title":"J Med Microbiol"},{"issue":"1","key":"10455_CR29","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/0003-9861(71)90044-0","volume":"145","author":"PH Lowy","year":"1971","unstructured":"Lowy PH, Sarmiento L, Mitchell HK (1971) Polypeptides minimine and melittin from bee venom: effects on Drosophila. Arch Biochem Biophys 145(1):338\u2013343. https:\/\/doi.org\/10.1016\/0003-9861(71)90044-0","journal-title":"Arch Biochem Biophys"},{"issue":"3","key":"10455_CR30","doi-asserted-by":"publisher","first-page":"e0149729","DOI":"10.1371\/journal.pone.0149729","volume":"11","author":"RC das Neves","year":"2016","unstructured":"das Neves RC, Trentini MM, de Castro e Silva J, Simon KS, Bocca AL, Silva LP, Mortari MR, Kipnis A, Junqueira-Kipnis AP (2016) Antimycobacterial activity of a new peptide polydim-I isolated from neotropical social wasp Polybia dimorpha. PLoS One 11(3):e0149729. https:\/\/doi.org\/10.1371\/journal.pone.0149729","journal-title":"PLoS One"},{"issue":"2","key":"10455_CR31","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.ijantimicag.2016.11.013","volume":"49","author":"JC Silva","year":"2017","unstructured":"Silva JC, Neto LM, Neves RC, Gon\u00e7alves JC, Trentini MM, Mucury-Filho R, Smidt KS, Fensterseifer IC, Silva ON, Lima LD, Clissa PB, Vilela N, Guilhelmelli F, Silva LP, Rangel M, Kipnis A, Silva-Pereira I, Franco OL, Junqueira-Kipnis AP, Bocca AL, Mortari MR (2017) Evaluation of the antimicrobial activity of the mastoparan Polybia-MPII isolated from venom of the social wasp Pseudopolybia vespiceps testacea (Vespidae, Hymenoptera). Int J Antimicrob Agents 49(2):167\u2013175. https:\/\/doi.org\/10.1016\/j.ijantimicag.2016.11.013","journal-title":"Int J Antimicrob Agents"},{"issue":"8","key":"10455_CR32","doi-asserted-by":"publisher","first-page":"1942","DOI":"10.1248\/cpb.27.1942","volume":"27","author":"Y Hirai","year":"1979","unstructured":"Hirai Y, Yasuhara T, Yoshida H, Nakajima T, Fujino M, Kitada C (1979) A new mast cell degranulating peptide \u201cmastoparan\u201d in the venom of Vespula lewisii. Chem Pharm Bull (Tokyo) 27(8):1942\u20131944. https:\/\/doi.org\/10.1248\/cpb.27.1942","journal-title":"Chem Pharm Bull (Tokyo)"},{"issue":"17","key":"10455_CR33","doi-asserted-by":"publisher","first-page":"8140","DOI":"10.1021\/acs.jmedchem.9b00915","volume":"62","author":"KG Oshiro","year":"2019","unstructured":"Oshiro KG, Candido ES, Chan LY, Torres MD, Monges BE, Rodrigues SG, Porto WF, Ribeiro SM, Henriques ST, Lu TK, de la Fuente-Nunez C, Craik DJ, Franco OL, Cardoso MH (2019) Computer-aided design of mastoparan-like peptides enables the generation of nontoxic variants with extended antibacterial properties. J Med Chem 62(17):8140\u20138151. https:\/\/doi.org\/10.1021\/acs.jmedchem.9b00915","journal-title":"J Med Chem"},{"key":"10455_CR34","doi-asserted-by":"publisher","first-page":"273","DOI":"10.3389\/fmicb.2017.00273","volume":"8","author":"MM Trentini","year":"2017","unstructured":"Trentini MM, das Neves RC, Santos BD, DaSilva RA, Souza AC, Mortari MR, Schwartz EF, Kipnis A, Junqueira-Kipnis AP (2017) Non-disulfide-bridge peptide 5.5 from the scorpion Hadrurus gertschi inhibits the growth of Mycobacterium abscessus subsp. massiliense. Front Microbiol 8:273. https:\/\/doi.org\/10.3389\/fmicb.2017.00273","journal-title":"Front Microbiol"},{"issue":"Pt 1","key":"10455_CR35","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1042\/0264-6021:3590035","volume":"359","author":"G Corzo","year":"2001","unstructured":"Corzo G, Escoubas P, Villegas E, Barnham KJ, He W, Norton RS, Nakajima T (2001) Characterization of unique amphipathic antimicrobial peptides from venom of the scorpion Pandinus imperator. Biochem J 359(Pt 1):35\u201345. https:\/\/doi.org\/10.1042\/0264-6021:3590035","journal-title":"Biochem J"},{"issue":"7","key":"10455_CR36","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0101742","volume":"9","author":"A Rodr\u00edguez","year":"2014","unstructured":"Rodr\u00edguez A, Villegas E, Montoya-Rosales A, Rivas-Santiago B, Corzo G (2014) Characterization of antibacterial and hemolytic activity of synthetic pandinin 2 variants and their inhibition against Mycobacterium tuberculosis. PLoS ONE 9(7):e101742. https:\/\/doi.org\/10.1371\/journal.pone.0101742","journal-title":"PLoS ONE"},{"key":"10455_CR37","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.peptides.2015.08.014","volume":"73","author":"S Ram\u00edrez-Carreto","year":"2015","unstructured":"Ram\u00edrez-Carreto S, Jim\u00e9nez-Vargas JM, Rivas-Santiago B, Corzo G, Possani LD, Becerril B, Ortiz E (2015) Peptides from the scorpion Vaejovis punctatus with broad antimicrobial activity. Peptides 73:51\u201359. https:\/\/doi.org\/10.1016\/j.peptides.2015.08.014","journal-title":"Peptides"},{"key":"10455_CR38","doi-asserted-by":"publisher","unstructured":"Guilhelmelli F, Vilela N, Smidt KS, De Oliveira MA, da Cunha Morales \u00c1lvares A, Rigonatto MC, da Silva Costa PH, Tavares AH, Freitas SM, Nicola AM, Franco OL, da Silveira Derengowski L, Schwartz EF, Mortari MR, Bocca AL, Albuquerque P, Silva-Pereira I (2016) Activity of scorpion venom-derived antifungal peptides against planktonic cells of Candida spp. and Cryptococcus neoformans and Candida albicans biofilms. Front Microbiol 7:1844. https:\/\/doi.org\/10.3389\/fmicb.2016.01844","DOI":"10.3389\/fmicb.2016.01844"},{"issue":"11","key":"10455_CR39","doi-asserted-by":"publisher","first-page":"2000151","DOI":"10.1002\/ardp.202000151","volume":"353","author":"EC da Mata","year":"2020","unstructured":"da Mata EC, Ombredane A, Joanitti GA, Kanzaki LI, Schwartz EF (2020) Antiretroviral and cytotoxic activities of Tityus obscurus synthetic peptide. Arch Pharm (Weinheim) 353(11):2000151. https:\/\/doi.org\/10.1002\/ardp.202000151","journal-title":"Arch Pharm (Weinheim)"},{"key":"10455_CR40","doi-asserted-by":"publisher","first-page":"109152","DOI":"10.1016\/j.biopha.2019.109152","volume":"118","author":"PHHV J\u00fanior","year":"2019","unstructured":"J\u00fanior PHHV, Simon KS, de Castro RJA, Coelho LC, Erazo FAH, de Souza ACB, das Neves RC, Lozano VF, Schwartz EF, Tavares AH, Mortari MR, Junqueira-Kipnis AP, Silva-Pereira I, Bocca AL (2019) Peptides ToAP3 and ToAP4 decrease release of inflammatory cytokines through TLR-4 blocking. Biomed Pharmacother 118:109152. https:\/\/doi.org\/10.1016\/j.biopha.2019.109152","journal-title":"Biomed Pharmacother"},{"key":"10455_CR41","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.toxicon.2021.08.012","volume":"201","author":"J Kr\u00e4mer","year":"2021","unstructured":"Kr\u00e4mer J, Peigneur S, Tytgat J, Jenner RA, van Toor R, Predel R (2021) A pseudoscorpion\u2019s promising pinch: the venom of Chelifer cancroides contains a rich source of novel compounds. Toxicon 201:92\u2013104. https:\/\/doi.org\/10.1016\/j.toxicon.2021.08.012","journal-title":"Toxicon"},{"issue":"1","key":"10455_CR42","doi-asserted-by":"publisher","first-page":"58","DOI":"10.3390\/toxins14010058","volume":"14","author":"J Kr\u00e4mer","year":"2022","unstructured":"Kr\u00e4mer J, L\u00fcddecke T, Marner M, Maiworm E, Eichberg J, Hardes K, Sch\u00e4berle TF, Vilcinskas A, Predel R (2022) Antimicrobial, insecticidal and cytotoxic activity of linear venom peptides from the pseudoscorpion Chelifer cancroides. Toxins 14(1):58. https:\/\/doi.org\/10.3390\/toxins14010058","journal-title":"Toxins"},{"issue":"2","key":"10455_CR43","doi-asserted-by":"publisher","first-page":"51","DOI":"10.3390\/toxins10020051","volume":"10","author":"A Figueroa-Montiel","year":"2018","unstructured":"Figueroa-Montiel A, Bern\u00e1ldez J, Jim\u00e9nez S, Ueberhide B, Gonz\u00e1lez LJ, Licea-Navarro A (2018) Antimycobacterial activity: a new pharmacological target for conotoxins found in the first reported conotoxin from Conasprella ximenes. Toxins 10(2):51. https:\/\/doi.org\/10.3390\/toxins10020051","journal-title":"Toxins"},{"issue":"2","key":"10455_CR44","doi-asserted-by":"publisher","first-page":"128","DOI":"10.3390\/toxins11020128","volume":"11","author":"J Bern\u00e1ldez-Sarabia","year":"2019","unstructured":"Bern\u00e1ldez-Sarabia J, Figueroa-Montiel A, Due\u00f1as S, Cervantes-Lu\u00e9vano K, Beltr\u00e1n JA, Ortiz E, Jim\u00e9nez S, Possani LD, Paniagua-Sol\u00eds JF, Gonzalez-Canudas J, Licea-Navarro A (2019) The diversified O-superfamily in Californiconus californicus presents a conotoxin with antimycobacterial activity. Toxins 11(2):128. https:\/\/doi.org\/10.3390\/toxins11020128","journal-title":"Toxins"},{"issue":"2","key":"10455_CR45","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/s0924-8579(03)00110-9","volume":"22","author":"JP Xie","year":"2003","unstructured":"Xie JP, Yue J, Xiong YL, Wang WY, Yu SQ, Wang HH (2003) In vitro activities of small peptides from snake venom against clinical isolates of drug-resistant Mycobacterium tuberculosis. Int J Antimicrob Agents 22(2):172\u2013174. https:\/\/doi.org\/10.1016\/s0924-8579(03)00110-9","journal-title":"Int J Antimicrob Agents"},{"issue":"1","key":"10455_CR46","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0190778","volume":"13","author":"A Sala","year":"2018","unstructured":"Sala A, Cabassi CS, Santospirito D, Polverini E, Flisi S, Cavirani S, Taddei S (2018) Novel Naja atra cardiotoxin 1 (CTX-1) derived antimicrobial peptides with broad spectrum activity. PLoS ONE 13(1):e0190778. https:\/\/doi.org\/10.1371\/journal.pone.0190778","journal-title":"PLoS ONE"},{"issue":"3","key":"10455_CR47","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1021\/bc100045s","volume":"22","author":"D Jha","year":"2011","unstructured":"Jha D, Mishra R, Gottschalk S, Wiesm\u00fcller KH, Ugurbil K, Maier ME, Engelmann J (2011) CyLoP-1: a novel cysteine-rich cell-penetrating peptide for cytosolic delivery of cargoes. Bioconjug Chem 22(3):319\u2013328. https:\/\/doi.org\/10.1021\/bc100045s","journal-title":"Bioconjug Chem"},{"issue":"7","key":"10455_CR48","doi-asserted-by":"publisher","first-page":"183895","DOI":"10.1016\/j.bbamem.2022.183895","volume":"1864","author":"A Priya","year":"2022","unstructured":"Priya A, Aditya A, Budagavi DP, Chugh A (2022) Tachyplesin and CyLoP-1 as efficient anti-mycobacterial peptides: a novel finding. Biochim Biophys Acta Biomembr 1864(7):183895. https:\/\/doi.org\/10.1016\/j.bbamem.2022.183895","journal-title":"Biochim Biophys Acta Biomembr"},{"key":"10455_CR49","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2022.824989","volume":"9","author":"CJC de Santana","year":"2022","unstructured":"de Santana CJC, Pires J\u00fanior OR, Fontes W, Palma MS, Castro MS (2022) Mastoparans: a group of multifunctional \u03b1-helical peptides with promising therapeutic properties. Front Mol Biosci 9:824989. https:\/\/doi.org\/10.3389\/fmolb.2022.824989","journal-title":"Front Mol Biosci"},{"key":"10455_CR50","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1007\/s10989-022-10401-5","volume":"28","author":"M Memariani","year":"2022","unstructured":"Memariani M, Memariani H, Poursafavi Z, Baseri Z (2022) Anti-fungal effects and mechanisms of action of wasp venom-derived peptide mastoparan-VT1 against Candida albicans. Int J Pept Res 28:96. https:\/\/doi.org\/10.1007\/s10989-022-10401-5","journal-title":"Int J Pept Res"},{"key":"10455_CR51","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.peptides.2013.07.014","volume":"48","author":"CJ Sample","year":"2013","unstructured":"Sample CJ, Hudak KE, Barefoot BE, Koci MD, Wanyonyi MS, Abraham S, Staats HF, Ramsburg EA (2013) A mastoparan-derived peptide has broad-spectrum antiviral activity against enveloped viruses. Peptides 48:96\u2013105. https:\/\/doi.org\/10.1016\/j.peptides.2013.07.014","journal-title":"Peptides"},{"key":"10455_CR52","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s41231-023-00145-9","volume":"8","author":"X Zhao","year":"2023","unstructured":"Zhao X, Luo W, Wang L, Zhu C, Xue X, Xia X, Wu X, Bai Y, Hu J (2023) Antimicrobial peptide Mastoparan X has good activity against Escherichia coli in vitro and alleviates its pathogenicity in mice. Transl Med Commun 8:22. https:\/\/doi.org\/10.1186\/s41231-023-00145-9","journal-title":"Transl Med Commun"},{"key":"10455_CR53","doi-asserted-by":"publisher","first-page":"3195","DOI":"10.1016\/j.bbamem.2016.09.021","volume":"12","author":"AL Hilchie","year":"1858","unstructured":"Hilchie AL, Sharon AJ, Haney EF, Hoskin DW, Bally MB, Franco OL, Corcoran JA (1858) Hancock RE (2016) Mastoparan is a membranolytic anti-cancer peptide that works synergistically with gemcitabine in a mouse model of mammary carcinoma. Biochim Biophys Acta 12:3195\u20133204. https:\/\/doi.org\/10.1016\/j.bbamem.2016.09.021","journal-title":"Biochim Biophys Acta"},{"key":"10455_CR54","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.toxicon.2016.07.009","volume":"120","author":"J Gon\u00e7alves","year":"2016","unstructured":"Gon\u00e7alves J, Rangel M, Biolchi A, Alves E, Moreira K, Silva L, Mortari M (2016) Antinociceptive properties of the mastoparan peptide Agelaia-MPI isolated from social wasps. Toxicon 120:15\u201321. https:\/\/doi.org\/10.1016\/j.toxicon.2016.07.009","journal-title":"Toxicon"},{"issue":"1","key":"10455_CR55","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.peptides.2012.04.018","volume":"36","author":"P Santos","year":"2012","unstructured":"Santos P, Gordillo A, Osses L, Salazar LM, Soto CY (2012) Effect of antimicrobial peptides on ATPase activity and proton pumping in plasma membrane vesicles obtained from mycobacteria. Peptides 36(1):121\u2013128. https:\/\/doi.org\/10.1016\/j.peptides.2012.04.018","journal-title":"Peptides"},{"key":"10455_CR56","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/bs.ircmb.2023.01.006","volume":"377","author":"S Nesci","year":"2023","unstructured":"Nesci S (2023) Bacterial and mammalian F1FO-ATPase: structural similarities and divergences to exploit in the battle against Mycobacterium tuberculosis. Int Rev Cell Mol Biol 377:45\u201363. https:\/\/doi.org\/10.1016\/bs.ircmb.2023.01.006","journal-title":"Int Rev Cell Mol Biol"},{"issue":"6","key":"10455_CR57","doi-asserted-by":"publisher","first-page":"219","DOI":"10.3390\/toxins10060219","volume":"10","author":"LM Marques-Neto","year":"2018","unstructured":"Marques-Neto LM, Trentini MM, Das Neves RC, Resende DP, Procopio VO, Da Costa AC, Kipnis A, Mortari MR, Schwartz EF, Junqueira-Kipnis AP (2018) Antimicrobial and chemotactic activity of scorpion-derived peptide, ToAP2, against Mycobacterium massiliensis. Toxins 10(6):219. https:\/\/doi.org\/10.3390\/toxins10060219","journal-title":"Toxins"},{"issue":"3","key":"10455_CR58","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/S1286-4579(01)01376-4","volume":"3","author":"J Pieters","year":"2001","unstructured":"Pieters J (2001) Entry and survival of pathogenic mycobacteria in macrophages. Microbes Infect 3(3):249\u2013255. https:\/\/doi.org\/10.1016\/S1286-4579(01)01376-4","journal-title":"Microbes Infect"},{"key":"10455_CR59","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1186\/1471-2164-8-119","volume":"8","author":"EF Schwartz","year":"2007","unstructured":"Schwartz EF, Diego-Garcia E, Rodr\u00edguez de la Vega RC, Possani LD (2007) Transcriptome analysis of the venom gland of the Mexican scorpion Hadrurus gertschi (Arachnida: Scorpiones). BMC Genomics 8:119. https:\/\/doi.org\/10.1186\/1471-2164-8-119","journal-title":"BMC Genomics"},{"issue":"13","key":"10455_CR60","doi-asserted-by":"publisher","first-page":"12316","DOI":"10.1074\/jbc.M413406200","volume":"280","author":"Y Chen","year":"2005","unstructured":"Chen Y, Mant CT, Farmer SW, Hancock RE, Vasil ML, Hodges RS (2005) Rational design of \u03b1-helical antimicrobial peptides with enhanced activities and specificity\/therapeutic index. J Biol Chem 280(13):12316\u201312329. https:\/\/doi.org\/10.1074\/jbc.M413406200","journal-title":"J Biol Chem"},{"issue":"11","key":"10455_CR61","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1007\/s11274-020-02948-6","volume":"36","author":"H Memariani","year":"2020","unstructured":"Memariani H, Memariani M, Robati RM, Nasiri S, Abdollahimajd F, Baseri Z, Moravvej H (2020) Anti-staphylococcal and cytotoxic activities of the short anti-microbial peptide PVP. World J Microbiol Biotechnol 36(11):174. https:\/\/doi.org\/10.1007\/s11274-020-02948-6","journal-title":"World J Microbiol Biotechnol"},{"issue":"4","key":"10455_CR62","doi-asserted-by":"publisher","first-page":"2497","DOI":"10.1529\/biophysj.104.043513","volume":"87","author":"K Nomura","year":"2004","unstructured":"Nomura K, Corzo G, Nakajima T, Iwashita T (2004) Orientation and pore-forming mechanism of a scorpion pore-forming peptide bound to magnetically oriented lipid bilayers. Biophys J 87(4):2497\u20132507. https:\/\/doi.org\/10.1529\/biophysj.104.043513","journal-title":"Biophys J"},{"issue":"6","key":"10455_CR63","doi-asserted-by":"publisher","first-page":"2568","DOI":"10.1073\/pnas.0915000107","volume":"107","author":"EE Ghosn","year":"2010","unstructured":"Ghosn EE, Cassado AA, Govoni GR, Fukuhara T, Yang Y, Monack DM, Bortoluci KR, Almeida SR, Herzenberg LA, Herzenberg LA (2010) Two physically, functionally, and developmentally distinct peritoneal macrophage subsets. Proc Natl Acad Sci U S A 107(6):2568\u20132573. https:\/\/doi.org\/10.1073\/pnas.0915000107","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10455_CR64","doi-asserted-by":"publisher","first-page":"225","DOI":"10.3389\/fimmu.2015.00225","volume":"6","author":"AD Cassado","year":"2015","unstructured":"Cassado AD, D\u2019Imp\u00e9rio Lima MR, Bortoluci KR (2015) Revisiting mouse peritoneal macrophages: heterogeneity, development, and function. Front Immunol 6:225. https:\/\/doi.org\/10.3389\/fimmu.2015.00225","journal-title":"Front Immunol"},{"issue":"13","key":"10455_CR65","doi-asserted-by":"publisher","first-page":"11049","DOI":"10.3390\/ijms241311049","volume":"24","author":"KS Simon","year":"2023","unstructured":"Simon KS, Coelho LC, Veloso PHHV Jr, Melo-Silva CA, Morais JAV, Longo JPF, Figueiredo F, Viana L, Silva Pereira I, Amado VM, Mortari MR, Bocca AL (2023) Innovative pre-clinical data using peptides to intervene in the evolution of pulmonary fibrosis. Int J Mol Sci 24(13):11049. https:\/\/doi.org\/10.3390\/ijms241311049","journal-title":"Int J Mol Sci"},{"key":"10455_CR66","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.toxicon.2019.02.009","volume":"162","author":"J Kr\u00e4mer","year":"2019","unstructured":"Kr\u00e4mer J, Pohl H, Predel R (2019) Venom collection and analysis in the pseudoscorpion Chelifer cancroides (Pseudoscorpiones: Cheliferidae). Toxicon 162:15\u201323. https:\/\/doi.org\/10.1016\/j.toxicon.2019.02.009","journal-title":"Toxicon"},{"issue":"6","key":"10455_CR67","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/0041-0101(93)90376-t","volume":"31","author":"CL Ownby","year":"1993","unstructured":"Ownby CL, Fletcher JE, Colberg TR (1993) Cardiotoxin 1 from cobra (Naja naja atra) venom causes necrosis of skeletal muscle in vivo. Toxicon 31(6):697\u2013709. https:\/\/doi.org\/10.1016\/0041-0101(93)90376-t","journal-title":"Toxicon"},{"key":"10455_CR68","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1096\/fj.03-1459fje","volume":"18","author":"A Kerkis","year":"2004","unstructured":"Kerkis A, Kerkis I, R\u00e1dis-Baptista G, Oliveira EB, Vianna-Morgante AM, Pereira LV, Yamane T (2004) Crotamine is a novel cell-penetrating protein from the venom of rattlesnake Crotalus durissus terrificus. FASEB J 18:1407\u20131409. https:\/\/doi.org\/10.1096\/fj.03-1459fje","journal-title":"FASEB J"},{"key":"10455_CR69","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.bbamem.2016.11.002","volume":"2","author":"N Ponnappan","year":"1859","unstructured":"Ponnappan N, Budagavi DP (1859) Chugh A (2017) CyLoP-1: membrane-active peptide with cell-penetrating and antimicrobial properties. Biochim Biophys Acta Biomembr 2:167\u2013176. https:\/\/doi.org\/10.1016\/j.bbamem.2016.11.002","journal-title":"Biochim Biophys Acta Biomembr"},{"issue":"5","key":"10455_CR70","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1016\/j.bbamem.2016.01.031","volume":"1858","author":"T Gutsmann","year":"2016","unstructured":"Gutsmann T (2016) Interaction between antimicrobial peptides and mycobacteria. Biochim Biophys Acta 1858(5):1034\u20131043. https:\/\/doi.org\/10.1016\/j.bbamem.2016.01.031","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"10455_CR71","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/s41579-019-0273-7","volume":"18","author":"CL Dulberger","year":"2020","unstructured":"Dulberger CL, Rubin EJ, Boutte CC (2020) The mycobacterial cell envelope\u2014a moving target. Nat Rev Microbiol 18(1):47\u201359. https:\/\/doi.org\/10.1038\/s41579-019-0273-7","journal-title":"Nat Rev Microbiol"},{"key":"10455_CR72","doi-asserted-by":"publisher","unstructured":"Daff\u00e9 M, Marrakchi H (2019) Unraveling the structure of the mycobacterial envelope. Microbiol Spectrum 7(4):GPP3\u20130027\u20132018. https:\/\/doi.org\/10.1128\/microbiolspec.GPP3-0027-2018","DOI":"10.1128\/microbiolspec.GPP3-0027-2018"},{"issue":"51","key":"10455_CR73","doi-asserted-by":"publisher","first-page":"10941","DOI":"10.1021\/acs.jpcb.3c06136","volume":"127","author":"T Brown","year":"2023","unstructured":"Brown T, Chavent M, Im W (2023) Molecular modeling and simulation of the mycobacterial cell envelope: from individual components to cell envelope assemblies. J Phys Chem B 127(51):10941\u201310949. https:\/\/doi.org\/10.1021\/acs.jpcb.3c06136","journal-title":"J Phys Chem B"},{"issue":"1","key":"10455_CR74","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.chembiol.2013.11.011","volume":"21","author":"H Marrakchi","year":"2014","unstructured":"Marrakchi H, Lan\u00e9elle MA, Daff\u00e9 M (2014) Mycolic acids: structures, biosynthesis, and beyond. Chem Biol 21(1):67\u201385. https:\/\/doi.org\/10.1016\/j.chembiol.2013.11.011","journal-title":"Chem Biol"},{"issue":"4","key":"10455_CR75","doi-asserted-by":"publisher","first-page":"e00218","DOI":"10.1128\/mSphere.00218-18","volume":"3","author":"DK-W Man","year":"2018","unstructured":"Man DK-W, Kanno T, Manzo G, Robertson BD, Lam JKW, Mason AJ (2018) Rifampin-or capreomycin-induced remodeling of the Mycobacterium smegmatis mycolic acid layer is mitigated in synergistic combinations with cationic antimicrobial peptides. mSphere 3(4):e00218-18. https:\/\/doi.org\/10.1128\/mSphere.00218-18","journal-title":"mSphere"},{"issue":"3","key":"10455_CR76","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1165\/rcmb.2018-0278OC","volume":"62","author":"JR Honda","year":"2020","unstructured":"Honda JR, Hess T, Carlson R, Kandasamy P, Nieto Ramirez LMN, Norton GJ, Virdi R, Islam MN, Mehaffy C, Hasan NA, Epperson LE, Hesser D, Alper S, Strong M, Flores SC, Voelker DR, Dobos KM, Chan ED (2020) Nontuberculous mycobacteria show differential infectivity and use phospholipids to antagonize LL-37. Am J Respir Cell Mol Biol 62(3):354\u2013363. https:\/\/doi.org\/10.1165\/rcmb.2018-0278OC","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10455_CR77","doi-asserted-by":"publisher","DOI":"10.1016\/j.biotechadv.2022.107962","volume":"59","author":"Z Lai","year":"2022","unstructured":"Lai Z, Yuan X, Chen H, Zhu Y, Dong N, Shan A (2022) Strategies employed in the design of antimicrobial peptides with enhanced proteolytic stability. Biotechnol Adv 59:107962. https:\/\/doi.org\/10.1016\/j.biotechadv.2022.107962","journal-title":"Biotechnol Adv"},{"key":"10455_CR78","doi-asserted-by":"publisher","unstructured":"Costa F, Teixeira C, Gomes P, Martins MCL (2019) Clinical application of AMPs. In: Matsuzaki, K. (eds) Antimicrobial peptides. Advances in experimental medicine and biology, vol 1117. Springer, Singapore. https:\/\/doi.org\/10.1007\/978-981-13-3588-4_15","DOI":"10.1007\/978-981-13-3588-4_15"},{"key":"10455_CR79","doi-asserted-by":"publisher","first-page":"1194923","DOI":"10.3389\/fimmu.2023.1194923","volume":"14","author":"YM Jacobo-Delgado","year":"2023","unstructured":"Jacobo-Delgado YM, Rodr\u00edguez-Carlos A, Serrano CJ, Rivas-Santiago B (2023) Mycobacterium tuberculosis cell-wall and antimicrobial peptides: a mission impossible? Front Immunol 14:1194923. https:\/\/doi.org\/10.3389\/fimmu.2023.1194923","journal-title":"Front Immunol"},{"issue":"3","key":"10455_CR80","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1111\/cbdd.12864","volume":"89","author":"H Memariani","year":"2017","unstructured":"Memariani H, Shahbazzadeh D, Ranjbar R, Behdani M, Memariani M, Pooshang Bagheri K (2017) Design and characterization of short hybrid antimicrobial peptides from pEM-2, mastoparan-VT 1, and mastoparan-B. Chem Biol Drug Des 89(3):327\u2013338. https:\/\/doi.org\/10.1111\/cbdd.12864","journal-title":"Chem Biol Drug Des"},{"issue":"2","key":"10455_CR81","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/j.drudis.2016.11.003","volume":"22","author":"N Qvit","year":"2017","unstructured":"Qvit N, Rubin SJ, Urban TJ, Mochly-Rosen D, Gross ER (2017) Peptidomimetic therapeutics: scientific approaches and opportunities. Drug Discov Today 22(2):454\u2013462. https:\/\/doi.org\/10.1016\/j.drudis.2016.11.003","journal-title":"Drug Discov Today"},{"issue":"4","key":"10455_CR82","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.tube.2014.03.011","volume":"94","author":"A Padhi","year":"2014","unstructured":"Padhi A, Sengupta M, Sengupta S, Roehm KH, Sonawane A (2014) Antimicrobial peptides and proteins in mycobacterial therapy: current status and future prospects. Tuberculosis 94(4):363\u2013373. https:\/\/doi.org\/10.1016\/j.tube.2014.03.011","journal-title":"Tuberculosis"},{"key":"10455_CR83","doi-asserted-by":"publisher","DOI":"10.1016\/j.peptides.2021.170666","volume":"146","author":"Y Han","year":"2021","unstructured":"Han Y, Zhang M, Lai R, Zhang Z (2021) Chemical modifications to increase the therapeutic potential of antimicrobial peptides. Peptides 146:170666. https:\/\/doi.org\/10.1016\/j.peptides.2021.170666","journal-title":"Peptides"},{"issue":"8","key":"10455_CR84","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1086\/424463","volume":"190","author":"A Kalita","year":"2004","unstructured":"Kalita A, Verma I, Khuller GK (2004) Role of human neutrophil peptide-1 as a possible adjunct to antituberculosis chemotherapy. J Infect Dis 190(8):1476\u20131480. https:\/\/doi.org\/10.1086\/424463","journal-title":"J Infect Dis"},{"issue":"7","key":"10455_CR85","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1016\/j.peptides.2004.04.003","volume":"25","author":"L Fattorini","year":"2004","unstructured":"Fattorini L, Gennaro R, Zanetti M, Tan D, Brunori L, Giannoni F, Pardini M, Orefici G (2004) In vitro activity of protegrin-1 and beta-defensin-1, alone and in combination with isoniazid, against Mycobacterium tuberculosis. Peptides 25(7):1075\u20131077. https:\/\/doi.org\/10.1016\/j.peptides.2004.04.003","journal-title":"Peptides"},{"issue":"6","key":"10455_CR86","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1016\/j.biomaterials.2013.11.035","volume":"35","author":"JS Khara","year":"2014","unstructured":"Khara JS, Wang Y, Ke XY, Liu S, Newton SM, Langford PR, Yang YY, Ee PLR (2014) Anti-mycobacterial activities of synthetic cationic \u03b1-helical peptides and their synergism with rifampicin. Biomaterials 35(6):2032\u20132038. https:\/\/doi.org\/10.1016\/j.biomaterials.2013.11.035","journal-title":"Biomaterials"},{"issue":"19","key":"10455_CR87","doi-asserted-by":"publisher","first-page":"7615","DOI":"10.1074\/jbc.RA118.006968","volume":"294","author":"Y Yang","year":"2019","unstructured":"Yang Y, Liu Z, He X, Yang J, Wu J, Yang H, Li M, Qian Q, Lai R, Xu W, Wei L (2019) A small mycobacteriophage-derived peptide and its improved isomer restrict mycobacterial infection via dual mycobactericidal-immunoregulatory activities. J Biol Chem 294(19):7615\u20137631. https:\/\/doi.org\/10.1074\/jbc.RA118.006968","journal-title":"J Biol Chem"},{"issue":"4","key":"10455_CR88","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s11274-023-03545-z","volume":"39","author":"H Memariani","year":"2023","unstructured":"Memariani H, Memariani M (2023) Antibiofilm properties of cathelicidin LL-37: an in-depth review. World J Microbiol Biotechnol 39(4):99. https:\/\/doi.org\/10.1007\/s11274-023-03545-z","journal-title":"World J Microbiol Biotechnol"},{"key":"10455_CR89","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioflm.2023.100107","volume":"5","author":"MC Mu\u00f1oz-Egea","year":"2023","unstructured":"Mu\u00f1oz-Egea MC, Akir A, Esteban J (2023) Mycobacterium biofilms. Biofilm 5:100107. https:\/\/doi.org\/10.1016\/j.bioflm.2023.100107","journal-title":"Biofilm"},{"issue":"3","key":"10455_CR90","doi-asserted-by":"publisher","first-page":"642","DOI":"10.3390\/pharmaceutics14030642","volume":"14","author":"JT Costa de Pontes","year":"2022","unstructured":"Costa de Pontes JT, Borges ABT, Roque-Borda CA, Pavan FR (2022) Antimicrobial peptides as an alternative for the eradication of bacterial biofilms of multi-drug resistant bacteria. Pharmaceutics 14(3):642. https:\/\/doi.org\/10.3390\/pharmaceutics14030642","journal-title":"Pharmaceutics"},{"issue":"6","key":"10455_CR91","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1080\/07388551.2023.2254932","volume":"44","author":"L Caselli","year":"2024","unstructured":"Caselli L, Rodrigues GR, Franco OL, Malmsten M (2024) Pulmonary delivery systems for antimicrobial peptides. Crit Rev Biotechnol 44(6):963\u2013980. https:\/\/doi.org\/10.1080\/07388551.2023.2254932","journal-title":"Crit Rev Biotechnol"},{"issue":"5","key":"10455_CR92","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1007\/s11095-022-03379-8","volume":"40","author":"J Li","year":"2023","unstructured":"Li J, Zheng H, Leung SS (2023) Pulmonary delivery of emerging antibacterials for bacterial lung infections treatment. Pharm Res 40(5):1057\u20131072. https:\/\/doi.org\/10.1007\/s11095-022-03379-8","journal-title":"Pharm Res"},{"issue":"3","key":"10455_CR93","doi-asserted-by":"publisher","first-page":"560","DOI":"10.3390\/nano10030560","volume":"10","author":"MC Teixeira","year":"2020","unstructured":"Teixeira MC, Carbone C, Sousa MC, Espina M, Garcia ML, Sanchez-Lopez E, Souto EB (2020) Nanomedicines for the delivery of antimicrobial peptides (AMPs). Nanomaterials 10(3):560. https:\/\/doi.org\/10.3390\/nano10030560","journal-title":"Nanomaterials"},{"issue":"11","key":"10455_CR94","doi-asserted-by":"publisher","first-page":"1840","DOI":"10.3390\/pharmaceutics13111840","volume":"13","author":"ME van Gent","year":"2021","unstructured":"van Gent ME, Ali M, Nibbering PH, K\u0142odzi\u0144ska SN (2021) Current advances in lipid and polymeric antimicrobial peptide delivery systems and coatings for the prevention and treatment of bacterial infections. Pharmaceutics 13(11):1840. https:\/\/doi.org\/10.3390\/pharmaceutics13111840","journal-title":"Pharmaceutics"},{"key":"10455_CR95","doi-asserted-by":"publisher","DOI":"10.1016\/j.carbpol.2023.121449","volume":"323","author":"LMDG Primo","year":"2024","unstructured":"Primo LMDG, Roque-Borda CA, Canales CSC, Caruso IP, de Louren\u00e7o IO, Colturato VMM, S\u00e1bio RM, de Melo FA, Vicente EF, Chorilli M, da Silva BH, Barbugli PA, Franzyk H, Paul Hansen PR, Pavan FR (2024) Antimicrobial peptides grafted onto the surface of N-acetylcysteine-chitosan nanoparticles can revitalize drugs against clinical isolates of Mycobacterium tuberculosis. Carbohydr Polym 323:121449. https:\/\/doi.org\/10.1016\/j.carbpol.2023.121449","journal-title":"Carbohydr Polym"},{"key":"10455_CR96","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2021.121097","volume":"608","author":"A Sharma","year":"2021","unstructured":"Sharma A, Gaur A, Kumar V, Sharma N, Patil SA, Verma RK, Singh AK (2021) Antimicrobial activity of synthetic antimicrobial peptides loaded in poly-\u0190-caprolactone nanoparticles against mycobacteria and their functional synergy with rifampicin. Int J Pharm 608:121097. https:\/\/doi.org\/10.1016\/j.ijpharm.2021.121097","journal-title":"Int J Pharm"},{"issue":"1","key":"10455_CR97","doi-asserted-by":"publisher","first-page":"7866","DOI":"10.1038\/s41598-019-44256-6","volume":"9","author":"R Sharma","year":"2019","unstructured":"Sharma R, Raghav R, Priyanka K, Rishi P, Sharma S, Srivastava S, Verma I (2019) Exploiting chitosan and gold nanoparticles for antimycobacterial activity of in silico identified antimicrobial motif of human neutrophil peptide-1. Sci Rep 9(1):7866. https:\/\/doi.org\/10.1038\/s41598-019-44256-6","journal-title":"Sci Rep"}],"container-title":["Probiotics and Antimicrobial Proteins"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12602-025-10455-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12602-025-10455-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12602-025-10455-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T06:41:51Z","timestamp":1746513711000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12602-025-10455-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,20]]},"references-count":97,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["10455"],"URL":"https:\/\/doi.org\/10.1007\/s12602-025-10455-z","relation":{},"ISSN":["1867-1306","1867-1314"],"issn-type":[{"value":"1867-1306","type":"print"},{"value":"1867-1314","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,20]]},"assertion":[{"value":"7 January 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Both authors gave final approval for publication.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}